WebbCancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). WebbA Phase II trial evaluating necitumumab combined with cisplatin and gemcitabine in stage 4 squamous cell lung cancer patients was completed, but results are currently not available (NCT01606748). This was an open-label trial that investigated the pharmacokinetics of the drug in combination with chemotherapy.
Breast Cancer Drug Trial Results in ‘Unheard-Of’ Survival
Webb14 apr. 2024 · Psilocybin-assisted therapy could help patients with cancer and major depression disorder, according to new data from an open-label Phase II trial published in JAMA Oncology.. Sunstone Therapies reported results from a 30-patient Phase II trial suggesting psilocybin and group therapy could lead to sustained reductions of … Webb12 apr. 2024 · The National Cancer Institute, part of the National Institutes of Health (NIH), has helped launch a phase 3 randomized clinical trial (NCT05633602) of a two-drug combination to treat patients with ... cub castle pigeon forge tn
Pragmatica-Lung Study opens for patient enrollment - NCI
WebbSponsors: Lead Sponsor: Sun Yat-sen University Source: Sun Yat-sen University Brief Summary: A multicenter, single-arm, open study to evaluate the safety and efficacy of Serplulimab in combination with bevacizumab and first-line chemotherapy in driver negative non-squamous NSCLC patients with brain metastases Webb9 feb. 2015 · There are now several epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) inhibitors approved that demonstrate a large magnitude of durable overall response rate (ORR) in patients with non–small-cell lung cancer (NSCLC) who harbor certain EGFR mutations and ALK rearrangements. 5 – 8 Webb3 feb. 2024 · Brief Summary: This Randomized Phase 3 Open-label Study will Evaluate the Efficacy of Zimberelimab (AB122) Monotherapy Compared to Standard Chemotherapy or Zimberelimab Combined with AB154 in Front-Line, PD-L1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer. Study Design Go to cub champlin hours